Giants of Cancer CareĀ® Program Inductees

Lung Cancer

Thomas J. Lynch, Jr, MD

Yale Cancer Center

  • Director, Yale Cancer Center and Physician-in-Chief, Smilow Cancer Hospital at Yale-New Haven.
  • Pioneered the use of molecular testing for mutations in the epidermal growth factor receptor (EGFR) gene to select patients who can benefit from targeted lung cancer therapies.
  • Internationally known for his leadership in the development of novel therapies for the treatment of lung cancer.
  • Pioneer in the field of personalized medicine.
Back to 2013 Inductees